🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 2, randomized, multicenter, parallel group, double-blind, d...
Status
Completed
Location
Lotus Clinical Research, LLC
Start Date
2014-07
Trial ID
NCT02199678
Treatments Being Tested
This study will compare the safety and tolerability of lyophilized BNT162b2...
Status
Completed
Location
Anaheim Clinical Trials, LLC
Start Date
2021-04-01
Trial ID
NCT04816669
Treatments Being Tested
Primary#Objectives #Immunogenicity:To demonstrate the non-inferiority of bi...
Status
Unknown
Location
Savannakhét Provincial hospital
Start Date
2022-10-19
Trial ID
NCT05686161
Treatments Being Tested
This will be the first-in-human (FIH) study with the oral formulation of CX...
Status
Completed
Location
Jasper Clinical Research & Development, Inc.
Start Date
2015-01
Trial ID
NCT02313064
Treatments Being Tested
The combination of EDs (ED) and post-traumatic sequelae of childhood trauma...
Status
Completed
Location
Modum Bad
Start Date
2015-08
Trial ID
NCT02649114
Treatments Being Tested
The goal of this study is to determine if patients with chronic periodontit...
Status
Unknown
Location
University of Valencia
Start Date
2011-11
Trial ID
NCT01532674
Title: Study of Inectolizumab Combined With Steroid Hormone Adjustment Stra...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-09
Trial ID
NCT07159893
Treatments Being Tested
Dolutegravir (DTG, GSK1349572) is a next-generation integrase inhibitor (IN...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-06
Trial ID
NCT01622790
The purpose of this study is to evaluate the immune response and safety of ...
Status
Completed
Location
GSK Investigational Site
Start Date
2024-03-22
Trial ID
NCT06331156
Treatments Being Tested
This is a randomized study of ASSIP as a treatment for patients who have re...
Status
Recruiting
Location
Region Skåne, psykiatri & habilitering, psykiatriforskning skane, Vuxenpsykiatri Lud
Start Date
2020-10-15
Trial ID
NCT04746261
Treatments Being Tested